SNX11
geneOn this page
Summary
SNX11 (sorting nexin 11, HGNC:14975) is a protein-coding gene on chromosome 17q21.32, encoding Sorting nexin-11 (Q9Y5W9). Phosphoinositide-binding protein involved in protein sorting and membrane trafficking in endosomes.
This gene encodes a member of the sorting nexin family. Members of this family contain a phox (PX) domain, which is a phosphoinositide binding domain, and are involved in intracellular trafficking. This protein does not contain a coiled coil region, like some family members. This gene encodes a protein of unknown function. This gene results in two transcript variants differing in the 5’ UTR, but encoding the same protein.
Source: NCBI Gene 29916 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_013323
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14975 |
| Approved symbol | SNX11 |
| Name | sorting nexin 11 |
| Location | 17q21.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000002919 |
| Ensembl biotype | protein_coding |
| OMIM | 614906 |
| Entrez | 29916 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 18 protein_coding, 2 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000359238, ENST00000393405, ENST00000452859, ENST00000577310, ENST00000578861, ENST00000580219, ENST00000580875, ENST00000581298, ENST00000581705, ENST00000582104, ENST00000582481, ENST00000583320, ENST00000584335, ENST00000883819, ENST00000883820, ENST00000883821, ENST00000883822, ENST00000913721, ENST00000913722, ENST00000913723, ENST00000913724, ENST00000960405, ENST00000960406
RefSeq mRNA: 3 — MANE Select: NM_013323
NM_001330320, NM_013323, NM_152244
CCDS: CCDS11526, CCDS82152
Canonical transcript exons
ENST00000359238 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001256504 | 48121235 | 48123601 |
| ENSE00001324714 | 48107766 | 48107838 |
| ENSE00003509394 | 48118974 | 48119186 |
| ENSE00003539166 | 48118704 | 48118799 |
| ENSE00003588413 | 48112031 | 48112085 |
| ENSE00003589295 | 48113301 | 48113401 |
| ENSE00003605195 | 48112574 | 48112660 |
Expression profiles
Bgee: expression breadth ubiquitous, 264 present calls, max score 93.11.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.1943 / max 177.2784, expressed in 1803 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161421 | 7.1423 | 1765 |
| 161420 | 4.7245 | 1560 |
| 161422 | 0.3275 | 104 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cervix squamous epithelium | UBERON:0006922 | 93.11 | silver quality |
| gingival epithelium | UBERON:0001949 | 92.88 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 92.82 | silver quality |
| pancreatic ductal cell | CL:0002079 | 92.56 | gold quality |
| monocyte | CL:0000576 | 92.31 | gold quality |
| leukocyte | CL:0000738 | 92.20 | gold quality |
| mononuclear cell | CL:0000842 | 92.13 | gold quality |
| granulocyte | CL:0000094 | 91.97 | gold quality |
| blood | UBERON:0000178 | 91.67 | gold quality |
| hair follicle | UBERON:0002073 | 90.50 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.97 | gold quality |
| gingiva | UBERON:0001828 | 89.48 | gold quality |
| islet of Langerhans | UBERON:0000006 | 88.83 | gold quality |
| inferior olivary complex | UBERON:0002127 | 88.51 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 88.41 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.35 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 87.62 | gold quality |
| squamous epithelium | UBERON:0006914 | 87.53 | gold quality |
| lymph node | UBERON:0000029 | 87.52 | gold quality |
| bone marrow | UBERON:0002371 | 87.15 | gold quality |
| spleen | UBERON:0002106 | 87.12 | gold quality |
| tonsil | UBERON:0002372 | 87.11 | gold quality |
| periodontal ligament | UBERON:0008266 | 86.97 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.94 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 86.92 | silver quality |
| vermiform appendix | UBERON:0001154 | 86.73 | gold quality |
| bone marrow cell | CL:0002092 | 86.40 | gold quality |
| caecum | UBERON:0001153 | 86.40 | gold quality |
| esophagus mucosa | UBERON:0002469 | 85.83 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.48 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- Structure of sorting nexin 11 (SNX11) reveals a novel extended phox homology (PX) domain critical for inhibition of SNX10-induced vacuolation. (PMID:23615901)
- penetration of Severe fever with thrombocytopenia syndrome virus from the endolysosomes into the cytoplasm of host cells was blocked in the cells lacking SNX11 (PMID:31215001)
- Molecular Basis for PI(3,5)P2 Recognition by SNX11, a Protein Involved in Lysosomal Degradation and Endosome Homeostasis Regulation. (PMID:32561432)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | snx11 | ENSDARG00000052522 |
| mus_musculus | Snx11 | ENSMUSG00000020876 |
| rattus_norvegicus | Snx11 | ENSRNOG00000008642 |
| drosophila_melanogaster | Snx1 | FBGN0031534 |
| drosophila_melanogaster | Snx6 | FBGN0032005 |
| caenorhabditis_elegans | WBGENE00004927 | |
| caenorhabditis_elegans | WBGENE00013354 |
Paralogs (15): SNX1 (ENSG00000028528), SNX10 (ENSG00000086300), SNX5 (ENSG00000089006), SNX8 (ENSG00000106266), SNX3 (ENSG00000112335), SNX4 (ENSG00000114520), SNX6 (ENSG00000129515), SNX9 (ENSG00000130340), SNX12 (ENSG00000147164), SNX30 (ENSG00000148158), SNX7 (ENSG00000162627), SNX32 (ENSG00000172803), SNX33 (ENSG00000173548), SNX18 (ENSG00000178996), SNX2 (ENSG00000205302)
Protein
Protein identifiers
Sorting nexin-11 — Q9Y5W9 (reviewed: Q9Y5W9)
All UniProt accessions (7): Q9Y5W9, B4DJI7, J3KTN6, J3QKV3, J3QLV8, J3QRB9, J3QRW4
UniProt curated annotations — full annotation on UniProt →
Function. Phosphoinositide-binding protein involved in protein sorting and membrane trafficking in endosomes. Regulates the levels of TRPV3 by promoting its trafficking from the cell membrane to lysosome for degradation.
Subunit / interactions. Monomer. Interacts with TRPV3; this interaction promotes TRPV3 trafficking from the cell membrane to lysosome for degradation.
Subcellular location. Cell membrane. Endosome. Cytoplasm.
Domain organisation. The PX domain mediates interaction with membranes enriched in phosphatidylinositol 3-phosphate.
Similarity. Belongs to the sorting nexin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y5W9-1 | 1 | yes |
| Q9Y5W9-2 | 2 |
RefSeq proteins (3): NP_001317249, NP_037455, NP_689450 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001683 | PX_dom | Domain |
| IPR036871 | PX_dom_sf | Homologous_superfamily |
| IPR043544 | SNX10/11 | Family |
Pfam: PF00787
UniProt features (25 total): helix 8, strand 5, binding site 3, mutagenesis site 2, region of interest 2, chain 1, domain 1, turn 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4IKD | X-RAY DIFFRACTION | 1.6 |
| 4IKB | X-RAY DIFFRACTION | 1.78 |
| 6KOK | X-RAY DIFFRACTION | 2 |
| 6KOJ | X-RAY DIFFRACTION | 2.14 |
| 6KOI | X-RAY DIFFRACTION | 3.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y5W9-F1 | 75.89 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 59; 85; 99
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 135–139 | impairs function in membrane trafficking. |
| 59 | abolishes lipid-binding. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 97 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_ORGANIZATION, BLALOCK_ALZHEIMERS_DISEASE_UP, DOUGLAS_BMI1_TARGETS_DN, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, TCCCRNNRTGC_UNKNOWN, GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING, GOMF_PHOSPHATIDYLINOSITOL_BINDING, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, GOMF_LIPID_BINDING, GOMF_PHOSPHOLIPID_BINDING, VERHAAK_GLIOBLASTOMA_NEURAL, IVANOVSKA_MIR106B_TARGETS, GOBP_INTRACELLULAR_TRANSPORT, TBK1.DF_UP
GO Biological Process (3): intracellular protein transport (GO:0006886), vesicle organization (GO:0016050), protein transport (GO:0015031)
GO Molecular Function (4): phosphatidylinositol phosphate binding (GO:1901981), protein binding (GO:0005515), lipid binding (GO:0008289), phosphatidylinositol binding (GO:0035091)
GO Cellular Component (5): cytoplasm (GO:0005737), endosome (GO:0005768), plasma membrane (GO:0005886), endomembrane system (GO:0012505), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| intracellular protein localization | 2 |
| binding | 2 |
| protein transport | 1 |
| intracellular transport | 1 |
| organelle organization | 1 |
| transport | 1 |
| establishment of protein localization | 1 |
| phospholipid binding | 1 |
| anion binding | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SNX11 | SNX24 | Q9Y343 | 638 |
| SNX11 | SNX22 | Q96L94 | 614 |
| SNX11 | SNX17 | Q15036 | 600 |
| SNX11 | SNX21 | Q969T3 | 528 |
| SNX11 | CDK5RAP3 | Q96JB5 | 521 |
| SNX11 | SNX14 | Q9Y5W7 | 519 |
| SNX11 | SNX15 | Q9NRS6 | 519 |
| SNX11 | SNX16 | P57768 | 519 |
| SNX11 | VPS29 | Q9UBQ0 | 510 |
| SNX11 | SNX32 | Q86XE0 | 501 |
| SNX11 | SNX27 | Q96L92 | 482 |
| SNX11 | SNX33 | Q8WV41 | 477 |
| SNX11 | TSNARE1 | Q96NA8 | 475 |
| SNX11 | ZER1 | Q7Z7L7 | 474 |
| SNX11 | TTLL6 | Q8N841 | 471 |
IntAct
58 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TNFRSF9 | TNFSF9 | psi-mi:“MI:0914”(association) | 0.820 |
| PKMYT1 | CCNB2 | psi-mi:“MI:0914”(association) | 0.730 |
| SNX11 | ARL6IP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SNX11 | RABAC1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ARL6IP1 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.720 |
| RABAC1 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.720 |
| RPRM | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZMYND10 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMYD2 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMYD1 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAJIN | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NECAB1 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REEP6 | SNX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AREG | ADCY9 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL16 | HSPD1 | psi-mi:“MI:0914”(association) | 0.530 |
| SNX11 | PML | psi-mi:“MI:0914”(association) | 0.530 |
| SNX11 | FANCL | psi-mi:“MI:0915”(physical association) | 0.400 |
| SUSD3 | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
| SNX11 | CHEK1 | psi-mi:“MI:0914”(association) | 0.350 |
| GLIPR1L2 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| RAB34 | RAP1GDS1 | psi-mi:“MI:0914”(association) | 0.350 |
| PNPLA4 | ATP2B3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (66): SNX11 (Two-hybrid), SNX11 (Two-hybrid), STK40 (Affinity Capture-MS), NPHP3 (Affinity Capture-MS), PML (Affinity Capture-MS), AP3B1 (Affinity Capture-MS), BMPR1A (Affinity Capture-MS), FGFR3 (Affinity Capture-MS), CHEK1 (Affinity Capture-MS), ZG16B (Affinity Capture-MS), PYCRL (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), ORC3 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), C18orf8 (Affinity Capture-MS)
ESM2 similar proteins: A1E2V0, A2AWP0, A6QPT6, A9JTP3, A9ULZ2, B1WBS3, O08863, O14771, O15037, O43918, O94966, P05433, P48778, P51617, Q08DD7, Q0P5G1, Q13077, Q15477, Q2LGB3, Q3TD16, Q3UJD6, Q499Z3, Q4R3B7, Q4R6Y5, Q5RA67, Q5XIS1, Q62210, Q62406, Q6AXX1, Q6J1Y9, Q75NR7, Q80U38, Q80VL3, Q811H0, Q8BHW9, Q8CFK6, Q8JHV9, Q8K330, Q8R2S1, Q8TE77
Diamond homologs: A0A1B7YDZ4, I1RXT2, O14243, O60107, O60493, O70492, O70493, P0CR58, P0CR59, P0CR60, P0CR61, P0CR62, P0CR63, P40959, P47057, Q08826, Q08DD7, Q1RMH8, Q2U4K2, Q2UB56, Q3MPQ4, Q4I1H6, Q4P1V3, Q4PHC3, Q4WQI6, Q4WWS3, Q4WZF1, Q522W5, Q5A748, Q5B797, Q5H7C3, Q5R5V1, Q5U211, Q6C2S9, Q6CTQ0, Q6CUC4, Q6FNH2, Q6FPT9, Q6FT03, Q75C43
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1039 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:48112569:TACAG:T | acceptor_loss | 1.0000 |
| 17:48112571:CA:C | acceptor_loss | 1.0000 |
| 17:48112572:A:C | acceptor_loss | 1.0000 |
| 17:48112573:GGA:G | acceptor_gain | 1.0000 |
| 17:48112661:G:GG | donor_gain | 1.0000 |
| 17:48113294:T:G | acceptor_gain | 1.0000 |
| 17:48113298:T:G | acceptor_gain | 1.0000 |
| 17:48113299:A:AG | acceptor_gain | 1.0000 |
| 17:48113300:G:GG | acceptor_gain | 1.0000 |
| 17:48113400:GT:G | donor_gain | 1.0000 |
| 17:48113402:G:GG | donor_gain | 1.0000 |
| 17:48118800:G:GG | donor_gain | 1.0000 |
| 17:48107659:G:GT | donor_gain | 0.9900 |
| 17:48112030:GAT:G | acceptor_gain | 0.9900 |
| 17:48112572:A:AG | acceptor_gain | 0.9900 |
| 17:48112572:AG:A | acceptor_gain | 0.9900 |
| 17:48112572:AGGAG:A | acceptor_gain | 0.9900 |
| 17:48112573:G:GG | acceptor_gain | 0.9900 |
| 17:48112573:GG:G | acceptor_gain | 0.9900 |
| 17:48112573:GGAGG:G | acceptor_gain | 0.9900 |
| 17:48112657:CCAT:C | donor_gain | 0.9900 |
| 17:48112658:CATG:C | donor_loss | 0.9900 |
| 17:48112660:TGTGA:T | donor_loss | 0.9900 |
| 17:48112661:GTG:G | donor_loss | 0.9900 |
| 17:48112662:TGAG:T | donor_loss | 0.9900 |
| 17:48112663:GA:G | donor_loss | 0.9900 |
| 17:48112664:A:AT | donor_loss | 0.9900 |
| 17:48112665:G:C | donor_loss | 0.9900 |
| 17:48113284:T:G | acceptor_gain | 0.9900 |
| 17:48113293:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
1745 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:48112593:T:A | V21D | 1.000 |
| 17:48112650:T:A | I40K | 1.000 |
| 17:48112650:T:G | I40R | 1.000 |
| 17:48113317:T:C | F49S | 1.000 |
| 17:48113343:C:A | R58S | 1.000 |
| 17:48112650:T:C | I40T | 0.999 |
| 17:48113302:C:T | T44I | 0.999 |
| 17:48113316:T:C | F49L | 0.999 |
| 17:48113318:T:A | F49L | 0.999 |
| 17:48113318:T:G | F49L | 0.999 |
| 17:48113331:T:C | S54P | 0.999 |
| 17:48113349:T:G | Y60D | 0.999 |
| 17:48113358:T:C | F63L | 0.999 |
| 17:48113359:T:C | F63S | 0.999 |
| 17:48113360:C:A | F63L | 0.999 |
| 17:48113360:C:G | F63L | 0.999 |
| 17:48113380:T:C | L70P | 0.999 |
| 17:48118781:T:C | L103P | 0.999 |
| 17:48118789:T:C | F106L | 0.999 |
| 17:48118791:C:A | F106L | 0.999 |
| 17:48118791:C:G | F106L | 0.999 |
| 17:48119014:C:G | H123D | 0.999 |
| 17:48119020:T:C | F125L | 0.999 |
| 17:48119021:T:C | F125S | 0.999 |
| 17:48119022:C:A | F125L | 0.999 |
| 17:48119022:C:G | F125L | 0.999 |
| 17:48119029:A:C | S128R | 0.999 |
| 17:48119031:C:A | S128R | 0.999 |
| 17:48119031:C:G | S128R | 0.999 |
| 17:48112643:T:G | Y38D | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000191654 (17:48106707 C>T), RS1000226766 (17:48108243 GTTAC>G), RS1000324571 (17:48115917 T>TG), RS1000404740 (17:48112478 A>G), RS1000531645 (17:48107284 C>T), RS1000598475 (17:48108602 A>G,T), RS1000631334 (17:48106427 A>G), RS1000662923 (17:48115138 T>A), RS1000666505 (17:48114511 G>A), RS1000734749 (17:48114810 C>T), RS1000739571 (17:48114072 T>G), RS1000778392 (17:48121197 G>C,T), RS1000933376 (17:48107790 A>G), RS1000964620 (17:48106829 T>C), RS1001414140 (17:48115927 G>T)
Disease associations
OMIM: gene MIM:614906 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001662_4 | Generalized epilepsy | 9.000000e-09 |
| GCST005951_17 | Body mass index | 3.000000e-09 |
| GCST010173_156 | Triglyceride levels | 3.000000e-08 |
| GCST010244_231 | Triglyceride levels | 2.000000e-18 |
| GCST90000025_594 | Appendicular lean mass | 2.000000e-17 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004530 | triglyceride measurement |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | increases expression | 1 |
| Vincristine | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): epilepsy